PTOV1 and prostate carcinoma: Because docetaxel resistant prostate cancer cells show an increased expression of PTOV1 (Figure 1B), we have determined the effects of its knockdown using two different shRNAs directed to different sequences of the gene PTOV1, in both docetaxel sensitive and resistant cells (Supplementary Figure 7A and 7B).